CROISSANCE LIMITED (CROISSANCE.BO)
INR 3.69
(-3.15%)
INR 3.69
(-3.15%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 11.01 Million | -490 Thousand | 7.38 Million | -2.9 Million | -15.31 Thousand |
| Net Income | 684 Thousand | 4.89 Million | 1.31 Million | 226.78 Thousand | 348.08 Thousand |
| Depreciation & Amortization | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 10.17 Million | -5.38 Million | 6.06 Million | -3.13 Million | -363.4 Thousand |
| Other non-cash items | -9.93 Million | 8.29 Million | -5.46 Million | 3.21 Million | 554.22 Thousand |
| Investing Cash Flow | -133 Thousand | 493 Thousand | -8.18 Million | -1.19 Million | - |
| Investments in PPE | -11.01 Million | - | - | - | - |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | -133 Thousand | 493 Thousand | -8.18 Million | -1.19 Million | - |
| Financing Cash Flow | -4.58 Million | - | 810.23 Thousand | 4.12 Million | - |
| Debt repayment | -4.58 Million | - | -810.23 Thousand | -4.12 Million | - |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - |
| Accounts receivables | 20.21 Million | -24.52 Million | 5.49 Million | -3.15 Million | -1.44 Million |
| Accounts payables | -10.12 Million | 16.22 Million | -29.6 Thousand | -66.23 Thousand | 891.45 Thousand |
| Inventory | - | - | - | - | - |
| Other working capital | 79 Thousand | 2.91 Million | 599.76 Thousand | 79.68 Thousand | 190.81 Thousand |
| Cash at beginning of period | 40 Thousand | 36.14 Thousand | 22.46 Thousand | 2403.00 | 17.72 Thousand |
| Cash at end of period | 6.34 Million | 40 Thousand | 36.14 Thousand | 22.46 Thousand | 2403.00 |
| Capital Expenditure | -11.01 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 6.3 Million | 3858.00 | 13.67 Thousand | 20.06 Thousand | -15.31 Thousand |
| Free Cash Flow | - | -490 Thousand | 7.38 Million | -2.9 Million | -15.31 Thousand |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 684 Thousand | 331 Thousand | 794 Thousand | 225 Thousand | 4.89 Million | 2.9 Million |
| Depreciation & Amortization | - | - | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 10.17 Million | - | - | - | -5.38 Million | - |
| Other non-cash items | -9.93 Million | -331 Thousand | -794 Thousand | -225 Thousand | 8.29 Million | -2.9 Million |
| Investing Cash Flow | -133 Thousand | - | - | - | 493 Thousand | - |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -133 Thousand | - | - | - | 493 Thousand | - |
| Financing Cash Flow | -4.58 Million | - | - | - | - | - |
| Debt repayment | -4.58 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 20.21 Million | - | - | - | -24.52 Million | - |
| Accounts payables | -10.12 Million | - | - | - | 16.22 Million | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 79 Thousand | - | - | - | 2.91 Million | - |
| Cash at beginning of period | 40 Thousand | 12 Thousand | -782 Thousand | 40 Thousand | 36.14 Thousand | -2.86 Million |
| Cash at end of period | 6.34 Million | 12 Thousand | 12 Thousand | 225 Thousand | 40 Thousand | 40 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.3 Million | - | 794 Thousand | 185 Thousand | 3858.00 | 2.9 Million |
| Free Cash Flow | 11.01 Million | - | 794 Thousand | 225 Thousand | -490 Thousand | 2.9 Million |
MSIU
BDR
308170
BGIP3
PARAGMILK
BIOFILCHEM